Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
PZ HTL SA
GLOBETECH PUBLISHING LLC

Researchers Employ High-Energy X-Ray to Image Living Cancer Cells

By BiotechDaily International staff writers
Posted on 13 Mar 2014
Image: X-ray scan of biologic cells: Each pixel represents a complete diffraction image. The color indicates how strong the X-rays are scattered at this local point (Photo courtesy of Britta Weinhausen, the University of Göttingen).
Image: X-ray scan of biologic cells: Each pixel represents a complete diffraction image. The color indicates how strong the X-rays are scattered at this local point (Photo courtesy of Britta Weinhausen, the University of Göttingen).
Scientists have performed the first studies of living biologic cells using high-energy X-rays. In the future, the new technique should make it possible to study unaltered living cells at high resolution.

“The new method for the first time enables us to investigate the internal structures of living cells in their natural environment using hard X-rays,” reported the researchers from the working group. “Thanks to the ever-greater resolution of the various investigative techniques, it is increasingly important to know whether the internal structure of the sample changes during sample preparation.” Scientists are working on the new research at the Deutsches Elektronen-Synchrotron DESY (Hamburg, Germany) PETRA III research light source. The new technology reveals distinct differences in the internal cellular structure between the living and dead, chemically fixed cells. “The new method for the first time enables us to investigate the internal structures of living cells in their natural environment using hard X-rays,” emphasized the leader of the working group, Prof. Sarah Köster from the Institute for X-Ray Physics of the University of Göttingen (Germany). The researchers published their findings on February 25, 2014, in the scientific journal Physical Review Letters.

Due to newly developed analytic methods with ever-higher resolution, scientists now can study biologic cells at the level of individual molecules. The cells are frequently chemically fixed before they are studied with the help of optical X-ray or electron microscopes. The process of chemical fixation involves immersing the cells in a type of chemical preservative that fixes all of the cell’s organelles and even the proteins in place. “Minor changes to the internal structure of the cells are unavoidable in this process,” stated Prof. Köster. “In our studies, we were able to show these changes in direct comparison for the first time.”

The scientists used cancer cells from the adrenal cortex for their study. They grew the cells on a silicon nitrite substrate, which is nearly transparent to X-rays. To keep the cells alive in the experimental chamber during the research, they were supplied with nutrients, and their metabolic products were driven away via fine channels only 0.5 mm in diameter. “The biological cells are thus located in a sample environment which very closely resembles their natural environment,” explained Dr. Britta Weinhausen from Prof. Köster’s group, the article’s first author.

The research was performed at the Nanofocus Setup (GINIX) of PETRA III’s experimental station P10. The scientists used the brilliant X-ray beam from PETRA III to scan the cells to gather data about their internal nanostructure. “Each frame was exposed for just 0.05 seconds, in order to avoid damaging the living cells too quickly,” clarified coauthor Dr. Michael Sprung from DESY. “Even nanometer-scale structures can be measured with the GINIX assembly, thanks to the combination of PETRA III’s high brilliance and the GINIX setup which is matched to the source.”

The researchers studied living and chemically fixed cells using this so-called nanodiffraction technique and compared the cells’ internal structures on the basis of the X-ray diffraction images. The results showed that the chemical fixation produces noticeable differences in the cellular structure on a scale of 30–50 nm.

“Thanks to the ever-greater resolution of the various investigative techniques, it is increasingly important to know whether the internal structure of the sample changes during sample preparation,” clarified Prof. Köster.

In the future, this new technology will make it possible to examine unchanged living cells at high resolution. Although other techniques have an even higher resolution than X-ray scattering, they require a chemical fixation or complex and invasive preparation of the cells. Lower-energy, so-called soft X-rays have already been used for studies of living cells. However, the study of structures with sizes as small as 12 nm first becomes possible through the analysis of diffraction images generated using hard X-rays.

Related Links:

Deutsches Elektronen-Synchrotron DESY
Institute for X-Ray Physics of the University of Göttingen



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: The new peptide offers a triple hormone effect in a single-cell molecule (Photo courtesy of Indiana University).

Tripeptide Drug Effectively Controls Metabolic Syndrome in Rodent Model

Promising results in reducing obesity and normalizing glucose metabolism obtained with a synthetic dipeptide drug have been enhanced by the addition of a molecule of a third hormone, glucagon.... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.